Labcorp Holdings Inc
LH261.500USD
+1.420+0.55%
Fechamento 08/01, 16:00（ET）Cotações atrasadas em 15 min
21.68BValor de mercado
29.66P/L TTM
Mais detalhes de Labcorp Holdings Inc Empresa
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Informações da empresa
Código da empresaLH
Nome da EmpresaLabcorp Holdings Inc
Data de listagemApr 24, 1991
Fundado em2024
CEOMr. Adam H. Schechter
Número de funcionários70000
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 24
Endereço358 S Main St
CidadeBURLINGTON
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal27215
Telefone13362291127
Sitehttps://www.labcorp.com/
Código da empresaLH
Data de listagemApr 24, 1991
Fundado em2024
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
98.96K
-5.81%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
30.07K
-6.24%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+9.59%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
12.89K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
12.84K
--
Ms. Richelle P. Parham
Ms. Richelle P. Parham
Independent Director
Independent Director
9.48K
--
Ms. Amy B. Summy
Ms. Amy B. Summy
Executive Vice President, Chief Marketing Officer
Executive Vice President, Chief Marketing Officer
5.30K
+16.66%
Ms. Kerrii B. Anderson, CPA
Ms. Kerrii B. Anderson, CPA
Independent Director
Independent Director
5.17K
-59.21%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
4.96K
--
Mr. Akinbolade Oyegunwa
Mr. Akinbolade Oyegunwa
Executive Vice President and Chief Information and Technology Officer
Executive Vice President and Chief Information and Technology Officer
3.46K
+16.48%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
98.96K
-5.81%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
30.07K
-6.24%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+9.59%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
12.89K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
12.84K
--
Ms. Richelle P. Parham
Ms. Richelle P. Parham
Independent Director
Independent Director
9.48K
--
Detalhamento da receita
Moeda: USDAtualizado em: qua, 12 de mar
Moeda: USDAtualizado em: qua, 12 de mar
FY2021
FY2020
FY2019
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
Northern America
13.09B
81.22%
Europe
2.05B
12.72%
Other Countries
976.40M
6.06%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sex, 16 de mai
Atualizado em: sex, 16 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
11.68%
BlackRock Institutional Trust Company, N.A.
5.56%
State Street Global Advisors (US)
4.62%
Select Equity Group, L.P.
2.68%
Geode Capital Management, L.L.C.
2.50%
Other
72.97%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
11.68%
BlackRock Institutional Trust Company, N.A.
5.56%
State Street Global Advisors (US)
4.62%
Select Equity Group, L.P.
2.68%
Geode Capital Management, L.L.C.
2.50%
Other
72.97%
Tipos de investidores
Investidores
Proporção
Investment Advisor
53.64%
Investment Advisor/Hedge Fund
34.33%
Research Firm
3.26%
Pension Fund
2.10%
Hedge Fund
1.84%
Bank and Trust
1.45%
Sovereign Wealth Fund
1.31%
Individual Investor
0.39%
Insurance Company
0.06%
Other
1.63%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
1819
81.60M
98.43%
-5.15M
2025Q1
1872
81.69M
97.58%
-5.17M
2024Q4
1872
81.10M
96.90%
-5.32M
2024Q3
1856
80.09M
95.55%
-6.82M
2024Q2
1876
81.29M
96.43%
-7.49M
2024Q1
1904
82.39M
97.73%
-8.65M
2023Q4
1947
83.11M
99.02%
-9.76M
2023Q3
1930
84.34M
99.29%
-7.18M
2023Q2
1934
84.05M
94.75%
-3.56M
2023Q1
1940
82.33M
92.89%
-5.93M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
9.69M
11.57%
+71.11K
+0.74%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
4.61M
5.5%
+61.07K
+1.34%
Mar 31, 2025
State Street Global Advisors (US)
3.83M
4.57%
+123.43K
+3.33%
Mar 31, 2025
Select Equity Group, L.P.
2.22M
2.65%
+624.10K
+39.11%
Mar 31, 2025
Geode Capital Management, L.L.C.
2.07M
2.47%
+64.83K
+3.24%
Mar 31, 2025
Allspring Global Investments, LLC
1.96M
2.34%
+40.81K
+2.13%
Mar 31, 2025
Diamond Hill Capital Management Inc.
1.95M
2.33%
-15.51K
-0.79%
Mar 31, 2025
BlackRock Financial Management, Inc.
1.85M
2.21%
-72.89K
-3.79%
Mar 31, 2025
Nordea Funds Oy
1.43M
1.71%
+374.30K
+35.55%
Mar 31, 2025
Fidelity Management & Research Company LLC
1.30M
1.56%
+88.25K
+7.26%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: há 6 horas
Atualizado em: há 6 horas
Nome
Proporção
iShares U.S. Healthcare Providers ETF
3.47%
Knowledge Leaders Developed World ETF
3.01%
Thrivent Small-Mid Cap ESG ETF
2.24%
iShares Health Innovation Active ETF
2.01%
Strategas Global Policy Opportunities ETF
1.97%
SPDR S&P Health Care Services ETF
1.93%
iShares Large Cap Value Active ETF
1.92%
Invesco S&P 500 Equal Weight Health Care ETF
1.67%
Brandes US Value ETF
1.62%
Franklin Genomic Advancements ETF
1.54%
Ver Mais
iShares U.S. Healthcare Providers ETF
Proporção3.47%
Knowledge Leaders Developed World ETF
Proporção3.01%
Thrivent Small-Mid Cap ESG ETF
Proporção2.24%
iShares Health Innovation Active ETF
Proporção2.01%
Strategas Global Policy Opportunities ETF
Proporção1.97%
SPDR S&P Health Care Services ETF
Proporção1.93%
iShares Large Cap Value Active ETF
Proporção1.92%
Invesco S&P 500 Equal Weight Health Care ETF
Proporção1.67%
Brandes US Value ETF
Proporção1.62%
Franklin Genomic Advancements ETF
Proporção1.54%
Dividendo
Um total de
692.30M
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Jan 09, 2025
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Mar 12, 2025 going ex on Feb 27, 2025
Feb 27, 2025
Mar 12, 2025
Feb 27, 2025
Oct 10, 2024
LH.NB Final Cash Dividend of gross USD 0.72 paid on Dec 13, 2024 going ex on Nov 26, 2024
Nov 26, 2024
Dec 13, 2024
Nov 26, 2024
Jul 25, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 13, 2024 going ex on Aug 29, 2024
Aug 29, 2024
Sep 13, 2024
Aug 29, 2024
Apr 11, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Jun 12, 2024 going ex on May 24, 2024
May 28, 2024
Jun 12, 2024
May 24, 2024
Jan 12, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Mar 13, 2024 going ex on Feb 26, 2024
Feb 27, 2024
Mar 13, 2024
Feb 26, 2024
Oct 12, 2023
LH.NB Final Cash Dividend of gross USD 0.72 paid on Dec 12, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Dec 12, 2023
Nov 07, 2023
Jul 13, 2023
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 08, 2023 going ex on Aug 07, 2023
Aug 08, 2023
Sep 08, 2023
Aug 07, 2023
Apr 06, 2023
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Jun 08, 2023 going ex on May 17, 2023
May 18, 2023
Jun 08, 2023
May 17, 2023
Jan 12, 2023
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Mar 13, 2023 going ex on Feb 22, 2023
Feb 23, 2023
Mar 13, 2023
Feb 22, 2023
Oct 12, 2022
LH.NB Final Cash Dividend of gross USD 0.72 paid on Dec 09, 2022 going ex on Nov 16, 2022
Nov 17, 2022
Dec 09, 2022
Nov 16, 2022
Ver Mais
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
